Whether a frosting reaction occurs after Q-switched laser treatment—and its intensity and depth—is primarily determined by four key factors: laser wavelength, lesion location, pigment density, and fluence. Understanding the interplay among these factors is essential for accurately gauging treatment endpoints and balancing efficacy with safety.

1. Laser Wavelength

Within the 200-1200nm spectrum, shorter wavelengths are more strongly absorbed by pigment. Consequently, shorter wavelengths trigger frosting at lower fluence and at shallower depths.

Conversely, longer wavelengths have lower pigment absorption, requiring higher fluence to induce frosting while penetrating more deeply into the skin. Notably, when frosting does occur with longer wavelengths, the resulting damage extends beyond the epidermis into the dermis.

2. Lesion Location

The depth of the pigmented lesion directly affects frosting behavior. Epidermal lesions produce rapid, superficial frosting, whereas dermal lesions require higher fluence to elicit a visible frosting response.

3. Pigment Density

Darker lesions indicate higher pigment content, greater density, and increased thickness. For any given Q‑switched wavelength, higher pigment density lowers the fluence threshold required for frosting. In other words, darker lesions are more readily fragmented but also more prone to excessive energy absorption.

4. Fluence

For a given wavelength and specific lesion, increasing fluence produces a cascade of effects:

• More pronounced frosting intensity;

• Deeper laser penetration into the skin;

• Enhanced pigment fragmentation;

• But also greater collateral skin damage.

5. Coexistence of Frosting and Delayed Reactions

Frosting and subsequent delayed (inflammatory) reactions coexist, but their dominance and intensity vary by wavelength:

Short-wavelength Q-switched lasers: Frosting is more intense and immediate;

Long-wavelength Q-switched lasers: Delayed effects are more pronounced, with inflammatory reactions appearing later and lasting longer.

In clinical practice, all four factors should be comprehensively evaluated, using appropriate frosting as the endpoint criterion to maximize fragmentation efficacy while minimizing the risk of skin injury.